Skip to main content
Caplight Logo









21st.BIO

21st.BIO

Private
DenmarkHealthcare & Life Scienceshttps://21st.bio/

Last Round

VC Round

Dec 21, 2021

Momentum

Top 10%

of companies Caplight tracks

Company Overview

21st.BIO is a bioindustrial company that provides a precision fermentation technology platform to help companies scale up from laboratory-level molecule innovation to cost-effective, large-scale production.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clean Manufacturing, Sustainable Materials

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

precision fermentationindustrial biotechnologybioprocessingstrain developmentscale-up servicesalternative proteinscellular agriculturebiomanufacturingfermentation technologymicrobial cell factorydownstream processingfood techtechnology licensingregulatory supportsynbio

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

21st.BIO Comparables

Compare 21st.BIO with similar companies based on industry and business-model similarity.

21st.BIO comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Cauldron
82%
Perfect Day
78%
The Protein Express
77%

21st.BIO Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundDec 21, 2021

Key People

Founding team and executive leadership

Thomas T. Kabel

Group CFO

Executive Team

21st.BIO Investors

Notable investors and investment history

21st.BIO investors
InvestorRounds
Novo HoldingsVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 1, 2026

    Open roles increased to 17, representing 26% of headcount.

  • Jul 20, 2026

    Open roles increased to 17, 26% of headcount.

21st.BIO Filings

Explore SEC and related filing metadata, where available.

21st.BIO filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about 21st.BIO's valuation, stock price, and market status.

Is 21st.BIO a public or private company?

21st.BIO is a private company.

What is the current stock price of 21st.BIO?

21st.BIO is a private company with no public stock price. No recent secondary market data is available.

How much is 21st.BIO worth (valuation)?

Valuation information for 21st.BIO is not publicly available.

Can I buy 21st.BIO stock?

21st.BIO shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was 21st.BIO's last funding round?

21st.BIO's most recent funding round was VC Round on December 21, 2021.

Who are the main investors in 21st.BIO?

Key investors in 21st.BIO include Novo Holdings.

Will 21st.BIO IPO soon?

No public IPO plans have been announced for 21st.BIO.

How can I track 21st.BIO secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor 21st.BIO's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersDenmark
Employee Range57
Year Founded2020
Last FundingDec 21, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?